Company intelligence / Profile preview

Isofarma

Eusébio, Ceará, Brazilhalexistar.com.br ↗

Ownership: Private
Employees: ~900
Development stage: Other

Overview

Isofarma is a Brazilian pharmaceutical company specializing in the development and manufacturing of small-volume parenteral solutions (SPPV) in plastic packaging. Founded in 1997 and based in Eusebio, Ceara, the company produces a wide range of injectable medicines, including electrolytes, glucose, antibiotics, and antiemetics, primarily for hospitals and clinics. In 2016, Isofarma was acquired by Halex Istar, a leading Brazilian provider of large-volume parenteral solutions, in a transaction backed by H.I.G. Capital. Today, the company operates as a key brand and manufacturing unit of Halex Istar, leveraging advanced technologies like Blow-Fill-Seal to supply healthcare facilities across Brazil.

Therapeutic areas: Metabolic DisordersInfectious DiseasesEndocrinologyGastroenterology
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Isofarma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Isofarma.